General considerations for designing phase Ⅱ clinical trials of new drugsWEI Min-ji, WANG Shui-qiang673-679
Measurement of China's pharmaceutical industry development level from the perspective of global value chainXU Fei, JIANG Rong, SHAO Rong680-684
A novel antipsychotic drug, SEP-363856TANG Jin-lei, SI Shu-ping, ZHAI Jin-guo, ZHAO Jing-ping, LIN Shuo685-689
Metformin plus berberine alleviates cognitive dysfunction in db/db miceCAO Yue-ying, MENG Xiang-bao, SUN Gui-bo, SUN Xiao-bo, SUN Yi, ZHAO Xin, PU Xiao-ping690-700
Correlation analysis between methotrexate serum concentration and renal function in children with medulloblastomaSHI Zheng-yuan, XU Xi-qiao, YANG Chun-jing, YANG Lu701-704
Progress in researches on drug transporters in lungZHANG Xiao-li, MAO Xin-yu, LI Zi-qiang, HUANG Yu-hong, WANG Bao-he705-711
Progress in evaluation and development of drugs for treatment of pulmonary fibrosisDENG Long, ZOU Xiao-qing, JIANG De-jian712-717
Evaluation of the clinical equivalence of biosimilars to their reference drugs in the treatment of rheumatoid arthritis: a Meta-analysisCHEN Yao, ZHOU Qing-xin, ZENG Bao-qi, YANG Ji-chun, GAO Le, YAN Yu-song, SUN Feng723-731
Molecular dynamics simulation study of glucagon-like peptide-1 receptorDU Xiao-xiao, MENG Fan-cui, LIU Wei, TANG Li-da732-739